Cargando…
Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study
INTRODUCTION: Methotrexate (MTX) is a cornerstone of treatment in a wide variety of inflammatory conditions, including juvenile idiopathic arthritis (JIA) and juvenile dermatomyositis (JDM). However, owing to its narrow therapeutic index and the considerable interpatient variability in clinical resp...
Autores principales: | Hawwa, Ahmed F., AlBawab, AbdelQader, Rooney, Madeleine, Wedderburn, Lucy R., Beresford, Michael W., McElnay, James C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619187/ https://www.ncbi.nlm.nih.gov/pubmed/26493320 http://dx.doi.org/10.1186/s13075-015-0814-z |
Ejemplares similares
-
A Novel Dried Blood Spot-LCMS Method for the Quantification of Methotrexate Polyglutamates as a Potential Marker for Methotrexate Use in Children
por: Hawwa, Ahmed F., et al.
Publicado: (2014) -
Health Care Apps Reported in Newspapers: Content Analysis
por: Al Bawab, Abdel Qader, et al.
Publicado: (2018) -
A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies
por: Martin, Neil, et al.
Publicado: (2011) -
Being on the juvenile dermatomyositis rollercoaster: a qualitative study
por: Livermore, Polly, et al.
Publicado: (2019) -
The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people
por: Mulligan, Kathleen, et al.
Publicado: (2015)